MENU
XERS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Xeris Biopharma Holdings (XERS) Ownership - Who owns Xeris Biopharma Holdings?

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States... Show more

Profile

Industry
Pharmaceuticals Major
Address
1375 West Fulton Street
Phone
+1 844 445-5704
Employees
377
Web
https://www.xerispharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
754.33M
P/E Ratio
N/A
Total Cash
58.44M
Projected Growth
N/A
Total Debt
268.75M
Revenue
222.55M
Risk (Beta)
0.64
Dividend Yield
N/A
Total Cash/Share
0.36
Total Debt/Equity
N/A
Revenue/Share
1.49 USD as % of share price

Fundamentals

XERS
Capitalization
754M
P/E Ratio
N/A
Risk (Beta)
0.64
Dividend Yield
N/A
Total Cash
58.4M
Total Cash/Share
0.36
Total Debt
269M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.49%
Revenue
223M
ROE
N/A
Book Value
-35.13M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.29
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
16K
Current Ratio
1.72
Current Revenue Per Employee
152586.30
Dividends Per Share - Security
N/A
EBITDA
-4.34M
Float
N/A
Float - Current
N/A
Gross Income Margin
85.48
Revenue To Assets
-13.83
Shares Held By Institutions
576M
Shares Outstanding - Current
160M
Total Liabilities
351M
Total Volume MTD
N/A
Value
-1
Gain YTD
38.938
View a ticker or compare two or three
XERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of ready-to-use, liquid-stable injectables

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1375 West Fulton Street
Phone
+1 844 445-5704
Employees
377
Web
https://www.xerispharma.com